# PGV: Anti-Phospholipase A2 Receptor

- Device class: 2; regulation: 21 CFR 866.5780; FDA's rule: 510(k) required
- FDA decisions: 2
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2014: 2

## Most-cited predicates
- DEN140002: Euroimmun Anti-PLA2R Ifa (2014), cited by 1

Source page: https://510kreport.com/product-code/PGV
Data by year (CSV): https://510kreport.com/product-code/PGV.csv